Dropless Cataract Surgery: Redefining Postoperative Care
-
By
February 9, 2026
-
6 min
Topical eye drops have traditionally been a mainstay in the postoperative care of cataract surgery, but dropless cataract surgery (DCS) now offers a viable alternative by administering medications intraoperatively. This shift addresses compliance issues inherent in traditional drop regimens, particularly for elderly patients experiencing challenges with medication administration. Evidence, including recent guidelines from the UKISCRS, suggests that DCS effectively improves patient outcomes, reduces healthcare costs, and aligns practice with sustainability goals. These recommendations emphasize the importance of intracameral antibiotics and subconjunctival corticosteroids while minimizing the reliance on postoperative drops.
1. Topical drops are common in cataract surgery recovery. 2. Dropless cataract surgery delivers meds during surgery. 3. Non-compliance with drops is prevalent, especially in elderly patients. 4. UKISCRS recommends intracameral antibiotics and subconjunctival steroids. 5. Dropless surgery reduces costs and environmental impact. 6. DCS aligns with current practices and patient-centered care. 7. Elderly patients benefit from reduced reliance on caregivers.
Listen Tab content
